Integra LifeSciences Holdings Corporation
IART · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,610,527 | $1,541,573 | $1,557,666 | $1,542,448 |
| % Growth | 4.5% | -1% | 1% | – |
| Cost of Goods Sold | $728,466 | $656,838 | $587,355 | $597,808 |
| Gross Profit | $882,061 | $884,735 | $970,311 | $944,640 |
| % Margin | 54.8% | 57.4% | 62.3% | 61.2% |
| R&D Expenses | $115,377 | $104,192 | $101,193 | $93,051 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $716,983 | $656,641 | $616,316 | $637,445 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21,290 | $12,376 | $13,882 | $16,914 |
| Operating Expenses | $853,650 | $773,209 | $731,391 | $747,410 |
| Operating Income | $28,411 | $111,526 | $238,920 | $197,230 |
| % Margin | 1.8% | 7.2% | 15.3% | 12.8% |
| Other Income/Exp. Net | -$46,648 | -$30,457 | -$25,026 | $17,447 |
| Pre-Tax Income | -$18,237 | $81,069 | $213,894 | $214,677 |
| Tax Expense | -$11,293 | $13,328 | $33,344 | $45,602 |
| Net Income | -$6,944 | $67,741 | $180,550 | $169,075 |
| % Margin | -0.4% | 4.4% | 11.6% | 11% |
| EPS | -0.09 | 0.87 | 2.18 | 2 |
| % Growth | -110.4% | -60.1% | 9% | – |
| EPS Diluted | -0.09 | 0.84 | 2.16 | 1.98 |
| Weighted Avg Shares Out | 77,010 | 78,169 | 82,997 | 84,698 |
| Weighted Avg Shares Out Dil | 77,010 | 80,337 | 83,516 | 85,485 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20,040 | $17,202 | $11,917 | $6,737 |
| Interest Expense | $70,632 | $51,377 | $49,594 | $50,395 |
| Depreciation & Amortization | $140,500 | $123,512 | $121,115 | $123,670 |
| EBITDA | $193,288 | $255,958 | $384,603 | $366,331 |
| % Margin | 12% | 16.6% | 24.7% | 23.7% |